Hello Heart Revenue, Valuation, Funding & Investors
Hello Heart is valued at $56M as of July 2019, a 1.2x multiple on its last reported $47M revenue.
Last Hello Heart valuation
$56M
Series B · Jul 2019
Last Hello Heart funding round
$70M
Series D · May 2022
Hello Heart revenue
$47M
Series B · Jul 2019
Key investors in Hello Heart
BlueRun Ventures
Resolute Ventures
Maven Ventures
Khosla Ventures
IVP
AAF Management Ltd.
About Hello Heart
Hello Heart is a digital therapeutics company offering a smartphone app with wireless blood pressure monitors for cardiovascular risk reduction. Tel Aviv-headquartered since 2014, it serves employer wellness programs in the US and Europe. Participants track readings daily, receiving personalized coaching on diet and exercise. Clinical trials show average reductions of 10 mmHg systolic BP, with partnerships including Pfizer and health plans covering millions of lives.
Founded
2013
HQ
San Francisco, CAWebsite
Status
Privately held
Customer focus
B2B
Revenue model
Subscription
Revenue
$47M (Jul 2019)
Valuation
$56M (Jul 2019)
Hello Heart Valuation
Hello Heart is currently valued at $56M, based on its Series B in July 2019.
The $12M round was led by Khosla Ventures, with participation from Maven Ventures, BlueRun Ventures, Resolute Ventures and AAF Management Ltd..
Hello Heart valuation by funding round
| Date | Stage | Valuation | Revenue Multiple |
|---|---|---|---|
| Jul 2019 | Series B | $56M | 1.2x |
Hello Heart Revenue
Hello Heart's latest recorded revenue is $47M, as of its Series B in July 2019. At a $56M valuation, that implies a 1.2x revenue multiple.
Hello Heart revenue by funding round
| Date | Revenue * | Valuation | Revenue Multiple | Stage |
|---|---|---|---|---|
| Jul 2019 | $47M | $56M | 1.2x | Series B |
* Revenue (or ARR) figures are the values recorded alongside each funding round. Typically run-rate revenue at the time of the deal, or a reported LTM (last 12 months) revenue.
Hello Heart Funding History
Hello Heart has raised a total of $138M across 6 funding rounds.
Hello Heart's first fundraising round was a $700K pre-seed round in October 2014. The most recent completed round was a $70M Series D in May 2022.
Hello Heart funding rounds
| Date | Stage | Investors | Raised | Valuation | Deal Summary |
|---|---|---|---|---|---|
| May 2022 | Series D | Stripes (lead); IVP; Maven Ventures; BlueRun Ventures; Resolute Ventures; Transform Capital | $70M | - | Hello Heart is an Israeli-founded digital therapeutics company specializing in heart health management, offering an FDA-cleared smartphone app paired with a wireless blood pressure monitor to track metrics like blood pressure, pulse, weight, activity, and blood sugar, while providing AI-driven personalized coaching, exercise, nutrition suggestions, and real-time alerts to prevent heart disease risks such as hypertension and hyperlipidemia. The app leverages behavioral science to improve user engagement and outcomes, positioning Hello Heart as the only dedicated fully digital program for preventive cardiovascular care, trusted by over 130 Fortune 500 employers, government entities, national health plans, and labor organizations. On May 2, 2022, Hello Heart closed a $70 million Series D funding round led by Stripes, with participation from IVP, Resolute Ventures, BlueRun Ventures, and Maven Ventures, bringing total funding to approximately $138-$140 million. CEO Maayan Cohen described the round as oversubscribed, noting the company as a 'baby unicorn' with respectable valuation, prioritizing business efficiency over rapid unicorn status ahead of a potential future IPO. The funding supports scaling amid surging employer demand for heart health solutions post-pandemic, with Hello Heart doubling its customer base since early 2022 and targeting another doubling by year-end, working with 60 Fortune 500 clients. Funds will enhance AI capabilities, expand beyond blood pressure to hyperlipidemia management, and fuel growth in the U.S. market where heart disease is the leading cause of death and cost driver. Hello Heart, founded in 2013 by Maayan Cohen, Ziv Meltzer, and Eran Keisar, maintains R&D in Israel (about one-third of its 130 employees) with U.S.-headquartered sales and marketing in Menlo Park, California. It is recognized on the American Heart Association’s Innovators’ Network and CVS Health platforms, emphasizing scalable solutions to close cardiac care gaps. |
| May 2021 | Series C | IVP (lead); Maven Ventures; BlueRun Ventures; Khosla Ventures; Resolute Ventures | $45M | - | Hello Heart is a Menlo Park, CA-based digital health company specializing in therapeutics solutions for heart health management, particularly hypertension through a platform that enables users to track blood pressure with connected monitors. The company raised $45 million in a Series C funding round on May 26, 2021, led by IVP, with participation from existing investors Khosla Ventures, BlueRun Ventures, Maven Ventures, and Resolute Ventures. This round supports broader expansion amid growing demand for digital health tools during and post-pandemic. At the time of the Series C, Hello Heart reported tripling its business in the prior year, driven by employer adoption of digital health solutions and new partnerships, including coverage by over 30 Fortune companies and integration into CVS Health’s digital health platform for PBM clients. The funds are earmarked for building engineering and go-to-market teams, hiring top talent, strengthening infrastructure, and expanding beyond hypertension to track additional heart conditions like arrhythmia, hyperlipidemia, and at-home ECG diagnostics. Hello Heart's prior funding history includes a $9.0 million round in March 2018 led by BlueRun Ventures and a $1.3 million undisclosed round in March 2015 from Resolute Ventures, contributing to total funding exceeding $149 million by some estimates. A later Series D round of $70 million occurred on May 2, 2022, with investors including Stripes Group, Google, and others. |
| Jul 2019 | Series B | Khosla Ventures (lead); Maven Ventures; BlueRun Ventures; Resolute Ventures; AAF Management Ltd. | $12M | $56M | Hello Heart is a digital health platform that helps patients manage hypertension and related conditions through an at-home Bluetooth-connected blood pressure monitor paired with a mobile app powered by machine learning. Founded in 2013 by two Israeli entrepreneurs and based in Palo Alto, California, the company provides personalized behavioral coaching and health tracking through its smartphone application, helping users understand and manage their blood pressure, blood sugar levels, medications, and physical activity without requiring live coaching. In July 2019, Hello Heart closed a $12 million Series B funding round led by Khosla Ventures, with participation from existing investors BlueRun Ventures, Maven Ventures, and Resolute Ventures. The round valued the company at $56.12 million post-money and brought total funding raised to $23 million. The capital was deployed to expand the company's sales and engineering teams, with a focus on scaling adoption across employers and health plans. The company demonstrated significant clinical traction prior to the Series B. A retrospective study of 5,000 Hello Heart users conducted by researchers from UCLA and Harvard Medical School found that 57% of participants reduced their blood pressure within four weeks and 69% within 22 weeks—results that the company stated were 2–3 times higher than outcomes from competing digital health solutions and traditional clinical studies. This clinical validation was central to attracting top-tier venture capital, with Vinod Khosla noting that Hello Heart was one of the few digital health solutions in hypertension with potential to move the needle on population health. |
| Mar 2018 | Series A | BlueRun Ventures (lead); Amicus Capital; Maven Ventures; Arba Ventures; Franklin Trust; Resolute Venture Partners; AAF Management Ltd.; Wanxiang America Healthcare Investments Group | $9M | - | - |
| Mar 2015 | Seed | Resolute Ventures (lead); BlueRun Ventures; Noam Bardin; Ran Makavy | $2M | - | - |
| Oct 2014 | Pre-seed | - | $700K | - | - |
Who has invested in Hello Heart?
15 investors have backed Hello Heart across its funding rounds, including BlueRun Ventures, Resolute Ventures, Maven Ventures, Khosla Ventures, IVP and AAF Management Ltd..
Lead investors include Stripes, IVP, Khosla Ventures, BlueRun Ventures and Resolute Ventures.
Hello Heart Investors
| Investor | HQ | Rounds | Role | First check |
|---|---|---|---|---|
| San Francisco, CA | 5 | Lead | Mar 2015 | |
| San Francisco, CA | 4 | Participant | Mar 2018 | |
| San Francisco, CA | 4 | Lead | Mar 2015 | |
| San Francisco, CA | 2 | Lead | May 2021 | |
| San Francisco, CA | 2 | Lead | Jul 2019 | |
| United States | 2 | Participant | Mar 2018 | |
 Bangalore | 1 | Participant | Mar 2018 | |
![](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="20" height="20" viewBox="0 0 20 20"><rect fill="%23e5e7eb" width="20" height="20" rx="4"/></svg>){kind=small} Arba Ventures | -- | 1 | Participant | Mar 2018 |
| Hartford, CT | 1 | Participant | Mar 2018 | |
| Noam Bardin |  Tel Aviv | 1 | Participant | Mar 2015 |
| United States | 1 | Participant | Mar 2018 | |
| Ran Makavy | San Francisco, CA | 1 | Participant | Mar 2015 |
| San Francisco, CA | 1 | Participant | May 2022 | |
This data is available for Pro users. Sign up to see all 15 Hello Heart investors. Start Free Trial | ||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialHello Heart Competitors
Hello Heart competitors include listed companies like Talkspace and Everkind Wellness, and private ones like United We Care, Vida Health, Casana and Health Recovery Solutions.
| Company | HQ | Status | Revenue | EBITDA | Valuation | Revenue Multiple |
|---|---|---|---|---|---|---|
| Los Angeles, CA | Private | - | - | $50M | - | |
| San Francisco, CA | Private | - | - | $53M | - | |
| Rochester, MN | Private | - | - | $42M | - | |
| Hoboken, NJ | Private | - | - | $37M | - | |
| United States | Publicly listed | $229M | $6M | $871M | 3.4x | |
 Canada | Publicly listed | - | - | $55M | - |
Hello Heart Public Comps
Hello Heart is still privately-owned, but its public comps include Everkind Wellness, EUDA Health, Zepp Health, Sleep Cycle, Rocket Doctor AI, TelyRx, Doctor Care Anywhere, 111, Keep Inc. and Healixa.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| - | - | - | - | - | - | |||
| $7M | ($2M) | 8.0x | 5.9x | (26.0x) | - | |||
| $259M | ($27M) | 0.9x | 0.8x | (9.0x) | (29.3x) | |||
| $24M | $7M | 1.4x | 1.5x | 4.6x | 9.6x | |||
| $1M | ($10M) | 34.6x | 20.7x | (4.3x) | (4.3x) | |||
| $43M | ($4M) | 0.8x | 0.4x | (8.7x) | (5.7x) | |||
| $51M | $6M | 0.6x | 0.6x | 5.5x | 4.5x | |||
| $1.9B | $3M | 0.0x | 0.0x | 15.8x | - | |||
This data is available for Pro users. Sign up to see all Hello Heart competitors and their valuation data. Start Free Trial | ||||||||
Common questions about Hello Heart
| When was Hello Heart founded? | Hello Heart was founded in 2013. |
| Where is Hello Heart headquartered? | Hello Heart is headquartered in San Francisco, CA, United States. |
| Is Hello Heart publicly listed? | No, Hello Heart is a private, VC-backed company. |
| What is Hello Heart's valuation? | Hello Heart was last valued at $56M in its Series B in July 2019. |
| How much funding has Hello Heart raised? | Hello Heart has raised $138M across 6 funding rounds. |
| What was Hello Heart's last funding round? | Hello Heart's last funding round was a $70M Series D in May 2022, led by Stripes. |
| Who are Hello Heart's investors? | Hello Heart's investors include BlueRun Ventures, Maven Ventures, Resolute Ventures, IVP, Khosla Ventures, AAF Management Ltd., Amicus Capital, Arba Ventures, Franklin Trust, Noam Bardin and 5 others. |
| What is Hello Heart's revenue? | Hello Heart's latest recorded revenue is $47M (July 2019). |
| What is Hello Heart's revenue multiple? | Hello Heart's latest valuation implies a 1.2x revenue multiple ($56M valuation on $47M of revenue). |
| Which companies are comparable to Hello Heart? | Companies comparable to Hello Heart include United We Care, Vida Health, Casana, Health Recovery Solutions, Talkspace and Everkind Wellness. |
See companies similar to Hello Heart
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.